Short answer

Units (U-100) = dose mg ÷ concentration mg/mL × 100. Example: 2.5 mg at 10 mg/mL is 25 units, or 0.25 mL. The answer changes with concentration, so there is no single number. Approved Zepbound and Mounjaro vials are labeled in mg per 0.5 mL; Lilly's instructions measure doses in mL, not units. As of Oct 19, 2026.

On this page10 sections
  1. The formula
  2. Tirzepatide mg-to-units chart
  3. Milligrams per unit
  4. How the FDA labels measure a dose
  5. A three-step check for any conversion
  6. The 2.4 mg question
  7. Where unit math goes wrong
  8. Use the calculator
  9. FAQ
  10. Sources
Key facts (as of Oct 19, 2026)
ItemValueSource
Single-dose pen or vial2.5 to 15 mg in 0.5 mL (5 to 30 mg/mL)DailyMed, Aug 28, 2026
Multi-dose vial dose volume0.6 mL per dose, 4 doses per vialDailyMed, Aug 28, 2026
Multi-dose vial concentrations4.17, 8.33, 12.5, 16.7, 20.8 or 25 mg/mLDailyMed, Aug 28, 2026
Label syringe instruction (vials)A syringe able to measure a 0.5 mL or 0.6 mL doseDailyMed, Aug 28, 2026
Mounjaro presentationsSame four presentations and strengths as ZepboundDailyMed, Aug 27, 2026
Compounded tirzepatideNot FDA approved; FDA describes dosing errors with compounded GLP-1sFDA, Oct 1, 2026
From vial to syringe: a tirzepatide worked example in three steps
  1. Vial and water

    30 mg + 3 mL

    The mg in the vial never changes; water only sets how spread out it is.

  2. Concentration

    30 ÷ 3 = 10 mg/mL

    Milligrams in every milliliter of solution.

  3. Units on a U-100 syringe

    2.5 mg ÷ 10 = 0.25 mL = 25 U

    100 units = 1 mL, so units = mL × 100 (rounded to 0.5 U).

People ask “how many units is 2.5 mg of tirzepatide” because syringes are marked in units and prescriptions are written in milligrams. The answer depends entirely on concentration. This page gives the conversion as arithmetic, shows it for the label dose strengths, and explains how the FDA labels themselves measure a dose.

The formula

Units = dose (mg) ÷ concentration (mg/mL) × 100

The “100” comes from the U-100 scale: 100 units per mL, so 1 unit = 0.01 mL. A unit is a volume mark. It says nothing about how much drug is in that volume until you know the concentration.

Worked example: a 2.5 mg dose from a 10 mg/mL solution is 2.5 ÷ 10 × 100 = 25 units, which is 0.25 mL.

Tirzepatide mg-to-units chart

U-100 units for each tirzepatide label dose at common concentrations (arithmetic: mg ÷ mg/mL × 100; blank where the volume exceeds 1 mL)
Dose5 mg/mL10 mg/mL15 mg/mL20 mg/mL30 mg/mL
2.5 mg50 U25 U16.7 U12.5 U8.3 U
5 mg100 U50 U33.3 U25 U16.7 U
7.5 mg—75 U50 U37.5 U25 U
10 mg—100 U66.7 U50 U33.3 U
12.5 mg——83.3 U62.5 U41.7 U
15 mg——100 U75 U50 U

A dash means the dose needs more than 1 mL at that concentration. Read along a row and the units fall as concentration rises: the same 2.5 mg is 50 units at 5 mg/mL and about 8 units at 30 mg/mL. That spread is why a unit number copied from someone else’s chart can be wrong for your vial.

The dose strengths in the rows are the six steps on the label ladder (see the tirzepatide dosage chart). The concentrations in the columns are examples; your product’s concentration is printed on its label.

Milligrams per unit

The reverse view is often easier to check.

Milligrams of tirzepatide in 1 unit and in 10 units, by concentration (arithmetic: mg/mL ÷ 100)
Concentrationmg per 1 unitmg per 10 unitsUnits in 1 mg
5 mg/mL0.05 mg0.5 mg20 U
10 mg/mL0.1 mg1 mg10 U
15 mg/mL0.15 mg1.5 mg6.7 U
20 mg/mL0.2 mg2 mg5 U
30 mg/mL0.3 mg3 mg3.3 U

At 30 mg/mL, a single unit holds 0.3 mg. A one-unit misread there is 12% of a 2.5 mg dose. At 5 mg/mL the same misread is 2% of the dose.

How the FDA labels measure a dose

The FDA-approved products sidestep unit math. Each single-dose pen and single-dose vial holds one dose in 0.5 mL, and each multi-dose vial or KwikPen holds four doses of 0.6 mL. (DailyMed, Aug 28, 2026) (DailyMed, Aug 27, 2026)

FDA-approved tirzepatide strengths and concentrations (Zepbound prescribing information, section 3, Aug 2026)
DoseSingle-dose pen or vialConcentrationMulti-dose vial or KwikPenConcentration
2.5 mg2.5 mg/0.5 mL5 mg/mL10 mg/2.4 mL4.17 mg/mL
5 mg5 mg/0.5 mL10 mg/mL20 mg/2.4 mL8.33 mg/mL
7.5 mg7.5 mg/0.5 mL15 mg/mL30 mg/2.4 mL12.5 mg/mL
10 mg10 mg/0.5 mL20 mg/mL40 mg/2.4 mL16.7 mg/mL
12.5 mg12.5 mg/0.5 mL25 mg/mL50 mg/2.4 mL20.8 mg/mL
15 mg15 mg/0.5 mL30 mg/mL60 mg/2.4 mL25 mg/mL
(DailyMed, Aug 28, 2026)

Notice the design. The concentration rises with the dose so the volume stays fixed: always 0.5 mL from a single-dose vial and 0.6 mL per dose from a multi-dose vial. For vials, the Zepbound label tells prescribers to have patients use “a syringe appropriate for dose administration (e.g., a 1 mL syringe capable of measuring a 0.5 mL or 0.6 mL dose).” (DailyMed, Aug 28, 2026)

So Lilly’s instructions are in mL. On a U-100 scale, 0.5 mL corresponds to the 50-unit mark and 0.6 mL to the 60-unit mark, for every strength. That is a conversion of the label volume, not a separate instruction. The pens need no conversion at all: the single-dose pen delivers its whole dose, and the KwikPen is set to its labeled dose. If your syringe or pen does not match what your label describes, ask your pharmacist before using it.

To compare a pen strength with a vial, the pen-to-vial converter does the matching.

A three-step check for any conversion

Doing the conversion in two stages makes errors easier to spot:

  1. Find the concentration in mg/mL on the label. If the label gives mg per volume (for example 7.5 mg/0.5 mL), divide: 7.5 ÷ 0.5 = 15 mg/mL.
  2. Convert the dose to mL: dose mg ÷ concentration. 7.5 mg ÷ 15 mg/mL = 0.5 mL.
  3. Convert mL to units: mL × 100. 0.5 mL × 100 = 50 units.
Worked conversions using the three-step check (arithmetic)
DoseConcentrationVolumeU-100 units
2.5 mg4.17 mg/mL (multi-dose vial)0.6 mL60 U
7.5 mg15 mg/mL0.5 mL50 U
12.5 mg25 mg/mL0.5 mL50 U
15 mg25 mg/mL (multi-dose vial)0.6 mL60 U

If step 2 gives a volume that does not match what your label or pharmacy instructions say, stop and ask before going further. A mismatch usually means the concentration was read wrong.

The 2.4 mg question

“2.4 mg is how many units” is one of the most common searches near this topic. 2.4 mg is the recommended Wegovy (semaglutide) maintenance dose for weight reduction in adults, not a tirzepatide label dose. (Novo Nordisk, Jun 18, 2026) The arithmetic is the same for any drug:

2.4 mg converted to U-100 units at several concentrations (arithmetic)
ConcentrationUnits for 2.4 mgVolume
5 mg/mL48 U0.48 mL
10 mg/mL24 U0.24 mL
20 mg/mL12 U0.12 mL
30 mg/mL8 U0.08 mL

If you meant semaglutide, the semaglutide units chart uses that drug’s label concentrations.

Where unit math goes wrong

The FDA’s page on unapproved GLP-1 drugs describes dosing errors with compounded products, and it states that compounded drugs are not FDA approved. (FDA, Oct 1, 2026) The arithmetic errors that lead to these mistakes are predictable:

  • Treating mg and units as the same number. 2.5 mg is not 2.5 units. At 10 mg/mL, 2.5 units would be 0.25 mg, a tenth of the intended dose.
  • Mixing up mL and units. 0.25 mL is 25 units, not 0.25 units.
  • Using a chart for a different concentration. A unit count only transfers between vials with the same mg/mL.
  • Forgetting that the concentration changed. A refill of a compounded product may come at a different strength. Recheck the label every time.

For powder vials, the concentration depends on how much water was added; the tirzepatide reconstitution chart covers that step.

Use the calculator

The tirzepatide units calculator takes any dose and concentration and returns units and mL, and flags volumes above 1 mL. It is a math tool. Your prescription label, your prescriber and your pharmacist set the dose and the volume. Background on the brands, approvals and trials is on the tirzepatide hub.

Frequently asked questions

How many units is 2.5 mg of tirzepatide?

It depends on the concentration. Units = mg ÷ (mg/mL) × 100. At 10 mg/mL, 2.5 mg is 25 units. At 5 mg/mL it is 50 units, at 20 mg/mL 12.5 units, and at 30 mg/mL about 8.3 units. The FDA-approved 2.5 mg single-dose vial holds 2.5 mg in 0.5 mL, and its label measures that dose in mL. Follow the label on your prescription.

What is the tirzepatide dosage chart in units?

There is no fixed units chart, because units measure volume. The chart on this page lists units for each label dose (2.5 to 15 mg) at 5, 10, 15, 20 and 30 mg/mL. Find the concentration printed on your vial or pharmacy label first, then read across.

2.4 mg is how many units?

2.4 mg is the recommended Wegovy (semaglutide) maintenance dose for weight reduction in adults, not a tirzepatide label dose. As arithmetic, 2.4 mg is 24 units at 10 mg/mL, 48 units at 5 mg/mL, 12 units at 20 mg/mL and 8 units at 30 mg/mL. For semaglutide, use the semaglutide units chart and the concentration on your own label.

How many units is 5 mg of tirzepatide?

At 10 mg/mL, 5 mg is 50 units (0.5 mL). At 20 mg/mL it is 25 units, and at 30 mg/mL about 16.7 units. The FDA-approved 5 mg single-dose vial holds 5 mg in 0.5 mL (10 mg/mL).

Are Zepbound vials measured in units?

No. The Zepbound label lists vials in mg per 0.5 mL (single-dose) or mg per 0.6 mL dose (multi-dose) and asks for a syringe that can measure a 0.5 mL or 0.6 mL dose. Any unit figure is a conversion of that volume. Ask your pharmacist if your syringe is marked differently from your label.

Sources

  1. ZEPBOUND (tirzepatide) injection, for subcutaneous use - Full Prescribing Information, Medication Guide and Instructions for Use (DailyMed SPL set ID 487cd7e7-434c-4925-99fa-aa80b1cc776b, version 40). U.S. National Library of Medicine (DailyMed) / Eli Lilly and Company, Aug 28, 2026. Accessed Oct 19, 2026.
  2. MOUNJARO (tirzepatide) injection, for subcutaneous use - Full Prescribing Information, Medication Guide and Instructions for Use (DailyMed SPL set ID d2d7da5d-ad07-4228-955f-cf7e355c8cc0, version 40). U.S. National Library of Medicine (DailyMed) / Eli Lilly and Company, Aug 27, 2026. Accessed Oct 19, 2026.
  3. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. U.S. Food and Drug Administration, Oct 1, 2026. Accessed Oct 19, 2026.
  4. WEGOVY (semaglutide) injection, for subcutaneous use; WEGOVY (semaglutide) tablets, for oral use - Full Prescribing Information (SPL, Revised 6/2026). Novo Nordisk / National Library of Medicine DailyMed, Jun 18, 2026. Accessed Oct 19, 2026.